Every Form 4 that Pharvaris N.V. (PHVS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PHVS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PHVS filings page.
Pharvaris N.V. Chief Medical Officer Lu Peng reported a routine tax-related share withholding. On April 16, 2026, 226 common shares were disposed of at a fair market value of $28.78 per share to satisfy tax withholding obligations from restricted stock units that vested on April 11 and April 12, 2026. After this non‑market transaction, Lu Peng directly held 66,083 common shares.
Pharvaris N.V. Chief Executive Officer Berndt Modig reported a small open-market sale of company stock. On April 16, 2026, he sold 2,292 shares of Pharvaris common stock at a weighted average price of $28.6032 per share in a series of trades executed under a Rule 10b5-1 trading plan. These sales involved shares that include stock previously acquired upon vesting of restricted stock units. After the sale, he directly owns 139,792 shares of common stock and also has an indirect holding of 950,000 shares through Schoodic Management BV, an entity he controls, indicating he retains a substantial overall stake in the company.
Pharvaris N.V. Principal Accounting Officer Anna Nijdam reported a routine tax-related share disposition. On the vesting of restricted stock units, the issuer withheld 548 shares of common stock at $26.63 per share to cover tax withholding obligations. After this withholding, Nijdam directly holds 48,940 common shares.
Pharvaris N.V. Chief Executive Officer Berndt Modig reported open-market sales of a total of 23,333 shares of common stock on April 9, 2026. The transactions were executed under a Rule 10b5-1 trading plan at weighted average prices of $27.7352 and $28.415 per share, across price ranges of $27.31–$28.30 and $28.32–$28.51. The shares sold include stock previously acquired upon vesting of restricted stock units. Following these sales, Modig holds 142,084 shares directly and 950,000 shares indirectly through Schoodif Management BV.
Pharvaris N.V. Principal Accounting Officer Anna Nijdam had 1,167 shares of Common Stock withheld by the company at $28.56 per share to cover tax obligations upon the vesting of restricted stock units. After this tax-withholding disposition, she directly holds 49,488 shares.
Pharvaris N.V.’s Principal Accounting Officer Anna Nijdam reported a routine tax-related share disposition. On the vesting of restricted stock units, 1,164 shares of common stock were withheld by the company at $28.25 per share to cover tax withholding obligations. After this withholding, Nijdam directly holds 50,655 shares of Pharvaris common stock. This was not an open-market sale but an administrative step tied to equity compensation.